Hydrus® Microstent New Enrollment Post-Approval Study
NCT: NCT04553523 · RECRUITING
Brief Summary
The purpose of this post-approval study is to evaluate the rate of Hydrus Microstent malposition and associated clinical sequelae occurring within 24 months post-operation. Qualified subjects will undergo uncomplicated cataract surgery with placement of a monofocal intraocular lens (IOL), followed by implantation of the Hydrus Microstent.
Frequently Asked Questions
What is Hydrus® Microstent New Enrollment Post-Approval Study?
Hydrus® Microstent New Enrollment Post-Approval Study is a clinical trial registered under NCT04553523. Current status: RECRUITING.
What is the status of NCT04553523?
The current status of NCT04553523 (Hydrus® Microstent New Enrollment Post-Approval Study) is: RECRUITING.
When did Hydrus® Microstent New Enrollment Post-Approval Study start?
Hydrus® Microstent New Enrollment Post-Approval Study started on 2020-08-25.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.